Alector_logo (1).png
Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
December 06, 2019 16:30 ET | Alector, Inc.
- Today’s AL002 presentation showcases the first data in humans with a TREM2 antibody - AL002 was generally safe and well-tolerated in healthy volunteers - Reduced CSF sTREM2 level demonstrates...
Dalmac Announces Resignation of Chief Financial Officer
December 06, 2019 16:30 ET | Dalmac Energy, Inc.
EDMONTON, Alberta, Dec. 06, 2019 (GLOBE NEWSWIRE) -- John Babic, President and CEO of Dalmac Energy Inc. (“Dalmac”) (TSX Venture “DAL”) announces effective December 3, 2019, Su Chun has resigned as...
logo JOF.jpg
Japan Smaller Capitalization Fund, Inc. Declares $0.2703 Ordinary Income Distribution, $0.1259 Short-Term Capital Gains Distribution, and $0.3464 Long-Term Capital Gains Distribution
December 06, 2019 16:30 ET | Japan Smaller Capitalization Fund
NEW YORK, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Japan Smaller Capitalization Fund, Inc. (NYSE: JOF) (the “Fund”) announced that it would make an ordinary income distribution of $0.2703 per share, a...
Flexion Logo.jpg
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 06, 2019 16:30 ET | Flexion Therapeutics, Inc.
BURLINGTON, Mass., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to six new employees consisting of an aggregate of 25,300 stock...
logo_new.jpg
ObsEva SA to Hold Conference Call to Discuss PRIMROSE 2 Trial Results on December 9, 2019
December 06, 2019 16:30 ET | ObsEva SA
  Geneva, Switzerland and Boston, MA –December 6, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s...
AHCLogo (1).jpg
A. H. Belo Corporation Announces First Quarter 2020 Dividend
December 06, 2019 16:30 ET | A.H. Belo Corporation
DALLAS, Dec. 06, 2019 (GLOBE NEWSWIRE) -- A. H. Belo Corporation (NYSE: AHC) announced today that the Company’s Board of Directors declared a quarterly cash dividend of $0.08 per share on...
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline – ABEO  
December 06, 2019 16:25 ET | Pomerantz LLP
NEW YORK, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ABEO) and certain...
Fortis_L.jpg
Fortis Inc. exerce son option de surallocation de 90 M$ CA dans le cadre du placement par voie de prise ferme précédemment annoncé
December 06, 2019 16:22 ET | Fortis
ST. JOHN’S, Terre-Neuve-et-Labrador, 06 déc. 2019 (GLOBE NEWSWIRE) -- Fortis Inc. (« Fortis » ou la « Société ») (TSX:FTS) (NYSE:FTS) a annoncé aujourd’hui l’émission d’un total de...
APRIL: Purchase agre
APRIL: Purchase agreement signed for the sale of Axeria IARD
December 06, 2019 16:21 ET | April
APRIL: Purchase agreement signed for the sale of Axeria IARD The APRIL Group announces today the signing of a share purchase agreement for the sale of Axeria IARD, a risk-carrying subsidiary...
watford.jpg
Watford Announces Declaration of Quarterly Dividend on Preference Shares
December 06, 2019 16:15 ET | Watford Holdings Ltd.
PEMBROKE, Bermuda, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Watford Holdings Ltd. ("Watford") (Nasdaq: WTRE) announced today that on December 31, 2019, it intends to pay to holders of record as of December...